A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.

@article{Sivaprasad2011APS,
  title={A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.},
  author={Sobha Sivaprasad and Sudeshna Patra and Joanna Dacosta and Temilade Adewoyin and Olajumoke Shona and Elizabeth A. Pearce and Ngaihang Victor Chong},
  journal={Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde},
  year={2011},
  volume={225 4},
  pages={200-6}
}
AIM To assess the safety and efficacy of the combined treatment of reduced-fluence verteporfin photodynamic therapy (PDT), intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for choroidal neovascularisa- tion (CNV) secondary to age-related macular degeneration (AMD). METHODS Nineteen patients with subfoveal CNV secondary to AMD were recruited into the trial. All study eyes (n = 19) received a single cycle of reduced-fluence (25 mJ/cm(2)) PDT with verteporfin followed by… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Reproduced with the permission

  • AG S.Karger, Basel
  • 2011

Similar Papers

Loading similar papers…